» Articles » PMID: 34320850

A Novel Gain-of-function Sodium Channel β2 Subunit Mutation in Idiopathic Small Fiber Neuropathy

Abstract

Small fiber neuropathy (SFN) is a common condition affecting thinly myelinated Aδ and unmyelinated C fibers, often resulting in excruciating pain and dysautonomia. SFN has been associated with several conditions, but a significant number of cases have no discernible cause. Recent genetic studies have identified potentially pathogenic gain-of-function mutations in several pore-forming voltage-gated sodium channel α subunits (Na) in a subset of patients with SFN, but the auxiliary sodium channel β subunits have been less implicated in the development of the disease. β subunits modulate Na trafficking and gating, and several mutations have been linked to epilepsy and cardiac dysfunction. Recently, we provided the first evidence for the contribution of a mutation in the β2 subunit to pain in human painful diabetic neuropathy. Here, we provide the first evidence for the involvement of a sodium channel β subunit mutation in the pathogenesis of SFN with no other known causes. We show, through current-clamp analysis, that the newly identified Y69H variant of the β2 subunit induces neuronal hyperexcitability in dorsal root ganglion neurons, lowering the threshold for action potential firing and allowing for increased repetitive action potential spiking. Underlying the hyperexcitability induced by the β2-Y69H variant, we demonstrate an upregulation in tetrodotoxin-sensitive, but not tetrodotoxin-resistant sodium currents. This provides the first evidence for the involvement of β2 subunits in SFN and strengthens the link between sodium channel β subunits and the development of neuropathic pain in humans. Small fiber neuropathy (SFN) often has no discernible cause, although mutations in the voltage-gated sodium channel α subunits have been implicated in some cases. We identify a patient suffering from SFN with a mutation in the auxiliary β2 subunit and no other discernible causes for SFN. Functional assessment confirms this mutation renders dorsal root ganglion neurons hyperexcitable and upregulates tetrodotoxin-sensitive sodium currents. This study strengthens a newly emerging link between sodium channel β2 subunit mutations and human pain disorders.

Citing Articles

Voltage-gated sodium channels in excitable cells as drug targets.

Alsaloum M, Dib-Hajj S, Page D, Ruben P, Krainer A, Waxman S Nat Rev Drug Discov. 2025; .

PMID: 39901031 DOI: 10.1038/s41573-024-01108-x.


Small Fiber Neuropathy in Burning Mouth Syndrome: A Systematic Review.

Kouri M, Adamo D, Vardas E, Georgaki M, Canfora F, Mignogna M Int J Mol Sci. 2024; 25(21).

PMID: 39518993 PMC: 11546372. DOI: 10.3390/ijms252111442.


Genetic Analysis of , , and in Familial Episodic Pain Syndrome (FEPS) in Japan and Proposal of Clinical Diagnostic Criteria.

Noguchi A, Tezuka T, Okuda H, Kobayashi H, Harada K, Yoshida T Int J Mol Sci. 2024; 25(13).

PMID: 38999942 PMC: 11241565. DOI: 10.3390/ijms25136832.


Trigeminal neuralgia.

Ashina S, Robertson C, Srikiatkhachorn A, Stefano G, Donnet A, Hodaie M Nat Rev Dis Primers. 2024; 10(1):39.

PMID: 38816415 DOI: 10.1038/s41572-024-00523-z.


Advances in diagnosis and management of distal sensory polyneuropathies.

Silsby M, Feldman E, Dortch R, Roth A, Haroutounian S, Rajabally Y J Neurol Neurosurg Psychiatry. 2023; 94(12):1025-1039.

PMID: 36997315 PMC: 10544692. DOI: 10.1136/jnnp-2021-328489.


References
1.
Laedermann C, Syam N, Pertin M, Decosterd I, Abriel H . β1- and β3- voltage-gated sodium channel subunits modulate cell surface expression and glycosylation of Nav1.7 in HEK293 cells. Front Cell Neurosci. 2013; 7:137. PMC: 3757325. DOI: 10.3389/fncel.2013.00137. View

2.
Chen C, Bharucha V, Chen Y, Westenbroek R, Brown A, Malhotra J . Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel beta 2-subunits. Proc Natl Acad Sci U S A. 2002; 99(26):17072-7. PMC: 139271. DOI: 10.1073/pnas.212638099. View

3.
Brouwer B, Merkies I, Gerrits M, Waxman S, Hoeijmakers J, Faber C . Painful neuropathies: the emerging role of sodium channelopathies. J Peripher Nerv Syst. 2014; 19(2):53-65. DOI: 10.1111/jns5.12071. View

4.
Nishikawa N, Nomoto M . Management of neuropathic pain. J Gen Fam Med. 2017; 18(2):56-60. PMC: 5689392. DOI: 10.1002/jgf2.5. View

5.
Israel M, Tanaka B, Castro J, Thongyoo P, Robinson S, Zhao P . Na 1.6 regulates excitability of mechanosensitive sensory neurons. J Physiol. 2019; 597(14):3751-3768. DOI: 10.1113/JP278148. View